Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Li, Li ^a   Zhang, Zhenwei ^b,c   Wang, Chengyu ^a   Miao, Lei ^d   Zhang, Jianpeng ^b   Wang, Jiasen ^a   Jiao, Binghua ^b   Zhao, Shuwei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Guangzhou 458 Hospital   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDASE; MIMECAN; NUCLEOLIN; PROFILIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CATION EXCHANGE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE CONTROL; HEP 2 CELL; HUMAN; LARYNX CARCINOMA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METASTASIS; NANOANALYSIS; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SWITZERLAND; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GENE SILENCING; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROFILINS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896347699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090181     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156. (Pubitemid 32911406)
2. Lefebvre JL (2006) Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 7: 747-755.
3. Tomasino RM, Bazan V, Daniele E, Nuara R, Morello V, et al. (1996) Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res 16: 2257-2267. (Pubitemid 26265575)
4. Medina JE, Ferlito A, Robbins KT, Silver CE, Rodrigo JP, et al. (2011) Central compartment dissection in laryngeal cancer. Head Neck 33: 746-752
5. Zvrko E, Mikić A, Jancić S (2012) Relationship of E-cadherin with cervical lymph node metastasis in laryngeal cancer. Coll Antropol. 2012 Nov;36 Suppl 2:119-24.
6. Herrmann PC, Liotta LA, Petricoin EF III (2001) Cancer proteomics: the state of the art. Dis Markers 17: 49-57. (Pubitemid 32964836)
7. Kavallaris M, Marshall GM (2005) Proteomics and disease: opportunities and challenges. Med J Aust 182: 575-579. (Pubitemid 40823476)
8. Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, et al. (2004) Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 1022: 295-305. (Pubitemid 38951617)
9. Ma Y, Peng J, Liu W, Zhang P, Huang L, et al. (2009) Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics 8: 1878-1890
10. DeSouza LV, Grigull J, Ghanny S, Dubé V, Romaschin AD, et al. (2007) Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 6: 1170-1182. (Pubitemid 47099227)
11. Zeng GQ, Zhang PF, Deng X, Yu FL, Li C, et al. (2012) Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics 11: M111.013946.
12. Wang JG, Xu WD, Zhai WT, Li Y, Hu JW, et al. (2012) Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study. Arthritis Rheum 64: 993-1004.
13. Moon PG, Kwack MH, Lee JE, Cho YE, Park JH, et al. (2013) Proteomic analysis of balding and non-balding mesenchyme-derived dermal papilla cells from androgenetic alopecia patients using on-line two-dimensional reversed phase-reversed phase LC-MS/MS. J Proteomics 85: 174-191.
14. Liu C, Pan C, Wang H, Yong L (2011) Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma. Tumour Biol 32: 1139-1145.
15. Cheng L, Zhou L, Tao L, Zhang M, Cui J, et al. (2009) Preliminary study of proteomic shift from normal to premalignant laryngeal lesions and to laryngeal squamous cell carcinoma. Acta Otolaryngol 129: 774-778.
16. Li ZB, Lehar M, Braga N, Westra W, Liu LH, et al. (2003) Study of human laryngeal muscle protein using two-dimensional electrophoresis and mass spectrometry. Proteomics 3: 1325-1334 (Pubitemid 36929555)
17. Sewell DA, Yuan CX, Robertson E (2007) Proteomic signatures in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69: 77-84.
18. Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, et al. (2008) Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 7: 1162-1173. (Pubitemid 351943962)
19. Ding Z, Lambrechts A, Parepally M, Roy P (2006) Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 119: 4127-4137. (Pubitemid 44650884)
20. Zhang Z, Zhang J, Miao L, Liu K, Yang S, et al. (2012) Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. Int J Biol Sci 8: 383-393.
21. Wu N, Zhang W, Yang Y, Liang YL, Wang LY, et al. (2006) Profilin 1obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 6: 6095-6106. (Pubitemid 44851394)
22. Peng L, Liang J, Wang H, Song X, Rashid A, et al. (2010) High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16: 3734-3742.
23. Zhang P, Chan DW, Zhu Y, Li JJ, Ng IO-L, et al. (2006) Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma. Clinical cancer research 12: 6617-6625. (Pubitemid 44876829)
24. Orr B, Riddick AC, Stewart GD, Anderson RA, Franco OE, et al. (2012) Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene 31: 1130-1142.
25. Witke W (2004) The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 14: 461-469.
26. Oien KA, Vass JK, Downie I, Fullarton G, Keith WN (2003) Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 22: 4287-4300. (Pubitemid 36876249)
27. Wu N, Zhang W, Yang Y, Liang YL, Wang LY, et al. (2006) Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 6: 6095-6106. (Pubitemid 44851394)
28. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, et al. (2000) Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 191: 1675-1686.
29. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, et al. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5: 157-171. (Pubitemid 43169348)
30. Mouneimne G, Hansen SD, Selfors LM, Petrak L, Hickey MM, et al. (2012) Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 22: 615-630.
31. Tajrishi MM, Tuteja R, Tuteja N (2011) Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 4: 267-275.
32. Angelov D, Bondarenko VA, Almagro S, Menoni H, Monge' lard F, et al. (2006) Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. EMBO J 25: 1669-1679.
33. Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, et al. (2003) Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem 278: 8572-8579. (Pubitemid 36800611)
34. Peng L, Liang J, Wang H, Song X, Rashid A, et al. (2010) High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16: 3734-3742.
35. Galzio R, Rosati F, Benedetti E, Cristiano L, Aldi S, et al. (2012) Glycosilated nucleolin as marker for human gliomas. J Cell Biochem 113: 571-579.
36. Mourmouras V, Cevenini G, Cosci E, Epistolato MC, Biagioli M, et al. (2009) Nucleolin protein expression in cutaneous melanocytic lesions. J Cutan Pathol 36: 637-646.
37. Zhao H, Huang Y, Xue C, Chen Y, Hou X, et al. (2013) Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer. PLoS One 8: e54674.
38. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, et al. (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278: 6521-6531. (Pubitemid 36800914)
39. Lee JH, Giovannetti E, Hwang JH, Petrini I, Wang Q, et al. (2012) Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer. Clin Cancer Res 18: 524-533.
40. Okamura N, Masuda T, Gotoh A, Shirakawa T, Terao S, et al. (2008) Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 8: 3194-3203.
41. Tripathi A, King C, De la Morenas A, Perry VK, Burke B, et al. (2008) Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer 122: 1557-1566. (Pubitemid 351294964)
42. Wang Y, Ma Y, Lü B, Xu E, Huang Q, et al. (2007) Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp Biol Med (Maywood) 232: 1152-1159. (Pubitemid 47503056)
43. Hu SM, Li F, Yu HM, Li RY, Ma QY, et al. (2005) The mimecan gene expressed in human pituitary and regulated by pituitary transcription factor-1 as a marker for diagnosing pituitary tumors. J Clin Endocrinol Metab 90: 6657-6664. (Pubitemid 41759329)
44. Zheng CX, Zhao SX, Wang P, Yu HM, Wang CF, et al. (2009) Different expression of mimecan as a marker for differential diagnosis between NSCLC and SCLC. Oncol Rep 22: 1057-1061.